Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional…
Latest News
-
-
Logan Mohtashami, a senior HousingWire analyst, believes mortgage rate stability – not rate cuts –…
-
On December 1st, famed investor Jim Cramer looked into the camera on CNBC’s Mad Money…
-
Analysts increasingly believe Microsoft could reach a $5 trillion market valuation in early 2026. The…
-
The S&P 500 Index and its ETFs, like SPY, VOO, and the IVV had a…
-
Gold prices slipped on Wednesday, but were on track for steepest annual gains since 1979.…
-
Nvidia stock (NASDAQ: NVDA) climbed on Wednesday after Reuters reported that the semiconductor giant has…
-
Tesla stock was mostly flat on Wednesday, the final trading day of 2025, capping a…
-
The “Dogs of the Dow” strategy has staged a comeback, and Kevin Simpson of Capital…
-
European markets and politics closed the year on sharply diverging trajectories. London stocks delivered their…